PRICE T ROWE ASSOCIATES INC /MD/ - G1 THERAPEUTICS INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$26
-42.2%
17,7550.0%0.00%
Q2 2023$45
-6.2%
17,7550.0%0.00%
Q1 2023$48
-81.3%
17,755
-62.5%
0.00%
Q4 2022$257
-100.0%
47,394
-0.8%
0.00%
Q3 2022$597,000
+153.0%
47,7650.0%0.00%
Q2 2022$236,000
-82.3%
47,765
-72.7%
0.00%
Q1 2022$1,332,000
-84.4%
175,225
-79.0%
0.00%
-100.0%
Q4 2021$8,519,000
-22.9%
834,427
+1.3%
0.00%0.0%
Q3 2021$11,055,000
-39.1%
823,742
-0.5%
0.00%
-50.0%
Q2 2021$18,157,000
-52.8%
827,589
-48.2%
0.00%
-50.0%
Q1 2021$38,468,000
+37.9%
1,598,848
+3.1%
0.00%
+33.3%
Q4 2020$27,901,000
+61.6%
1,550,910
+3.7%
0.00%
+50.0%
Q3 2020$17,267,000
-54.9%
1,495,019
-5.2%
0.00%
-60.0%
Q2 2020$38,263,000
+132.8%
1,577,196
+5.7%
0.01%
+66.7%
Q1 2020$16,436,000
-65.5%
1,491,444
-17.2%
0.00%
-50.0%
Q4 2019$47,579,000
+14.7%
1,800,184
-1.2%
0.01%0.0%
Q3 2019$41,496,000
-5.0%
1,821,595
+27.9%
0.01%0.0%
Q2 2019$43,679,000
+76.6%
1,424,609
-4.4%
0.01%
+50.0%
Q1 2019$24,737,000
-24.0%
1,490,167
-12.3%
0.00%
-33.3%
Q4 2018$32,540,000
-67.9%
1,699,199
-12.5%
0.01%
-60.0%
Q3 2018$101,516,000
+67.7%
1,941,412
+39.3%
0.02%
+66.7%
Q2 2018$60,548,000
+46.5%
1,393,198
+24.9%
0.01%
+28.6%
Q1 2018$41,321,0001,115,2680.01%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
MPM BioImpact LLC 856,798$6,512,0001.75%
CHI Advisors LLC 488,635$3,714,0001.58%
Pinz Capital Management, LP 186,515$1,418,0000.88%
Lombard Odier Asset Management (Switzerland) SA 542,183$4,121,0000.32%
Rhenman & Partners Asset Management AB 316,137$2,403,0000.24%
Birchview Capital, LP 40,000$304,0000.22%
NEEDHAM INVESTMENT MANAGEMENT LLC 160,000$1,216,0000.18%
Tekla Capital Management LLC 423,869$3,221,0000.11%
Golden Green, Inc. 12,152$92,0000.08%
Virtus ETF Advisers LLC 15,188$115,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders